Effects of 1alpha, 25-dihydroxyvitamin D3 on programmed cell death of Ishikawa endometrial cancer cells through ezrin phosphorylation

被引:7
|
作者
Kim, Tae-Hee [1 ]
Park, Junsik [2 ]
Lee, Jeong-Sang [3 ]
Lee, Hae-Hyeog [1 ]
机构
[1] Soonchunhyang Univ, Dept Obstet & Gynecol, Coll Med, Bucheon, South Korea
[2] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Lab Immunol & Infect Dis, Daejeon, South Korea
[3] Jeonju Univ, Dept Funct Food & Biotechnol, Coll Med Sci, Jeonju, South Korea
基金
新加坡国家研究基金会;
关键词
Apoptosis; calcitriol; endometrial neoplasms; membrane proteins; vitamin D; VITAMIN-D; COLORECTAL-CANCER; PROSTATE-CANCER; ERM PROTEINS; CYTOCHROME-C; SIGNALING PATHWAYS; FERM DOMAIN; BINDING; RISK; ASSOCIATION;
D O I
10.1080/01443615.2016.1271777
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
This study investigated the effects of 1, 25-dihydroxyvitamin D-3-induced cell death and its underlying molecular mechanisms in Ishikawa endometrial carcinoma cells. The effects of 1, 25-dihydroxyvitamin D-3 on Ishikawa cells were examined by 3-[4,5-dimethylthiazol-2-yl]-2.5-diphenyl-tetrazolium bromide, thiazolyl blue (MTT) assay. 1, 25-dihydroxyvitamin D-3 was shown to induce programmed cell death in Ishikawa endometrial carcinoma cells by activation of caspase-3 and caspase-9, along with elevation of Bcl-2 and Bcl-xL. Cell viability was reduced by 1, 25-dihydroxyvitamin D-3 in a concentration-dependent manner up to 2.5M. In addition, ezrin phosphorylation increased with the 1, 25-dihydroxyvitamin D-3 concentration (0-0.5M). The protein level of caspase-9 was increased by 1, 25-dihydroxyvitamin D-3 up to 0.5M. This is the first report regarding the efficacy and molecular mechanisms underlying the effects of 1, 25-dihydroxyvitamin D-3 in endometrial cancer cells. Our findings indicate that 1, 25-dihydroxyvitamin D-3 induces endometrial cancer cell death in a concentration-dependent manner.Impact statementUp to date, there is no report about the efficacy and molecular underlying mechanisms on the effect of vitamin D-3 in endometrial cancer cells. Our findings indicate that 1, 25-dihydroxyvitamin D-3. which is an active metabolite of vitamin D-3, induces Ishikawa endometrial cancer cell death in a concentration-dependent manner by activation of caspase-3 and -9, along with elevation of Bcl-2 and Bcl-xL. In addition, the same concentration of 1, 25-dihydroxyvitamin D-3 that provoked apoptotic signals caused phosphorylation of ezrin at threonine 567 in a VDR-dependent manner. This study suggests that 1, 25-dihydroxyvitamin D-3 within the optimal range (0.5 uM) would induce apoptosis through Fas-ezrin-caspase-3, -8, -9 signalling axis which may be a critical cell death regulator in Ishikawa endometrial cancer cell. Further study will be more interesting to address molecular connections or prove this critical optimal concentration range of vitamin D.
引用
收藏
页码:503 / 509
页数:7
相关论文
共 50 条
  • [21] INCREASED INTESTINAL CHROMATIN TEMPLATE ACTIVITY - INFLUENCE OF 1ALPHA,25-DIHYDROXYVITAMIN D3 AND HORMONE RECEPTOR COMPLEXES
    ZERWEKH, JE
    LINDELL, TJ
    HAUSSLER, MR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1976, 251 (08) : 2388 - 2394
  • [22] Characterization of 3-epi-1α,25-dihydroxyvitamin D3 involved in 1α,25-dihydroxyvitamin D3 metabolic pathway in cultured cell lines
    Masuda, S
    Kamao, M
    Schroeder, NJ
    Makin, HLJ
    Jones, G
    Kremer, R
    Rhim, J
    Okano, T
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2000, 23 (02) : 133 - 139
  • [23] Protective effects of 1 alpha,25-Dihydroxyvitamin D3 on cultured neural cells exposed to catalytic iron
    Uberti, Francesca
    Morsanuto, Vera
    Bardelli, Claudio
    Molinari, Claudio
    PHYSIOLOGICAL REPORTS, 2016, 4 (11):
  • [24] Effect of 1α,25-Dihydroxyvitamin D3 in Embryonic Hippocampal Cells
    Marini, Francesca
    Bartoccini, Elisa
    Cascianelli, Giacomo
    Voccoli, Vladimir
    Baviglia, Maria Gioia
    Magni, Mariapia Viola
    Garcia-Gil, Mercedes
    Albi, Elisabetta
    HIPPOCAMPUS, 2010, 20 (06) : 696 - 705
  • [25] Nonclassical effects of 1α,25-dihydroxyvitamin D3 and its analogs
    Verstuyf, A
    Verlinden, L
    Segaert, S
    Van Etten, E
    Mathieu, C
    Bouillon, R
    MINERAL AND ELECTROLYTE METABOLISM, 1999, 25 (4-6) : 345 - 348
  • [26] Apoptosis induction by 1α,25-dihydroxyvitamin D3 in prostate cancer
    Guzey, M
    Kitada, S
    Reed, JC
    MOLECULAR CANCER THERAPEUTICS, 2002, 1 (09) : 667 - 677
  • [27] BINDING CHARACTERISTICS OF A MEMBRANE-RECEPTOR THAT RECOGNIZES 1ALPHA,25-DIHYDROXYVITAMIN D-3 AND ITS EPIMER, 1-BETA,25-DIHYDROXYVITAMIN D-3
    BARAN, DT
    RAY, R
    SORENSEN, AM
    HONEYMAN, T
    HOLICK, MF
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, 56 (04) : 510 - 517
  • [28] 1α,25-dihydroxyvitamin D3 modulates the interaction between immune and colon cancer cells
    Bessler, Hanna
    Djaldetti, Meir
    BIOMEDICINE & PHARMACOTHERAPY, 2012, 66 (06) : 428 - 432
  • [29] Calcitrol (1α,25-dihydroxyvitamin D3) inhibits androgen glucuronidation in prostate cancer cells
    Kaeding, Jenny
    Belanger, Julie
    Caron, Patrick
    Verreault, Melanie
    Belanger, Alain
    Barbier, Olivier
    MOLECULAR CANCER THERAPEUTICS, 2008, 7 (02) : 380 - 390
  • [30] Suppression of Prostate Cancer Cell Rolling and Adhesion to Endothelium by 1α,25-Dihydroxyvitamin D3
    Hsu, Jong-Wei
    Yasmin-Karim, Sayeda
    King, Michael R.
    Wojciechowski, Joel C.
    Mickelsen, Deanne
    Blair, Martha L.
    Ting, Huei-Ju
    Ma, Wen-Lung
    Lee, Yi-Fen
    AMERICAN JOURNAL OF PATHOLOGY, 2011, 178 (02): : 872 - 880